The agency’s 2023 decision to place 19 peptides on the “unsafe” list was supported by numerous documented safety concerns, ...

Beverly Hills spine surgeon and principal investigator will present pooled clinical outcomes following recent FDA ...

The Trump administration announced changes to patient cost-sharing in Medicare’s prescription drug benefit and will update the methodology used to rate private Medicare Advantage plans.

FDA issues guidance compounded GLP-1 production limits, restricting pharmacies to compound only during active shortages to ...

The US Food and Drug Administration (FDA) has cited a medical device manufacturer and a contract drug testing laboratory for ...

Sri Lanka drugs and medical supplies requirements are met through three sources. The State hospital system is supplied by the ...

We are very proud of this result. A no‑483 outcome is a testament to the discipline, expertise, and dedication of our ...

Restore Robotics today announced it has received additional 510(k) clearances from the U.S. Food and Drug Administration (FDA ...

Meeting Global Demand for Comfort, Functionality, and Sustainable Bedding Solutions CALIFORNIA, CA, UNITED STATES, ...

Research by an Indiana University faculty member is at the heart of new bipartisan legislation that would amend the Federal ...

IND Filing and Concurrent RMAT Request Position XytriX™ as a Potential Breakthrough Biotherapeutic for More Than 500 ...

The US Food and Drug Administration (FDA) has warned an oncology drug company for repeatedly overstating the efficacy of its drug in advertisements while failing to adequately disclose the associated ...